Overview
Investor fact sheet
News
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2024 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2024 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2023 Health for Humanity Report
2023 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Go to jnj.com
Skip to main content
Latest news
Our company
Careers
Investors
Media center
Development pipeline
Overview
Investor fact sheet
News
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2024 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2024 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2023 Health for Humanity Report
2023 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Go to jnj.com
Selecting the value will change the page content
Search by Drug Name. Typing will change the displayed drugs.
Therapeutic
Therapeutic Area
All
Changes
Changes
All
Newly Added
Newly Advanced
Phase
Phase
All
Phase 1
Phase 2
Phase 3
Registration
Phase 1
Phase 2
Phase 3
Registration
total indications.
Download report
(opens in new window)
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com